{
  "id": "5e4601293f54159529000002",
  "type": "factoid",
  "question": "Central Vein Sign is characteristic to which disease?",
  "ideal_answer": "Central vein sign on FLAIR* magnetic resonance imaging  is highly specific and sensitive for multiple sclerosis.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28820013",
    "http://www.ncbi.nlm.nih.gov/pubmed/31796822",
    "http://www.ncbi.nlm.nih.gov/pubmed/30213803",
    "http://www.ncbi.nlm.nih.gov/pubmed/29369733",
    "http://www.ncbi.nlm.nih.gov/pubmed/29328521",
    "http://www.ncbi.nlm.nih.gov/pubmed/29565219",
    "http://www.ncbi.nlm.nih.gov/pubmed/27300318",
    "http://www.ncbi.nlm.nih.gov/pubmed/27834394",
    "http://www.ncbi.nlm.nih.gov/pubmed/31424490",
    "http://www.ncbi.nlm.nih.gov/pubmed/29514948",
    "http://www.ncbi.nlm.nih.gov/pubmed/31668125"
  ],
  "snippets": [
    {
      "text": "Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28820013",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "BACKGROUND: Detection of a \"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis (MS). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28820013",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSION: A simplified determination of CVS in three white matter lesions on 3T FLAIR* MRI demonstrated good specificity and sensitivity and fair inter-rater reliability for a diagnosis of MS and with further study, may be a candidate for clinical application.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28820013",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29328521",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Detection of perivenular lesions in the brain (the \"central vein sign\") improves the pathological specificity of MS diagnosis, but comprehensive evaluation of this MRI biomarker in MS-mimicking inflammatory and/or autoimmune diseases, such as central nervous system (CNS) inflammatory vasculopathies, is lacking.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29328521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTERPRETATION: The central vein sign differentiates inflammatory CNS vasculopathies from MS at standard clinical magnetic field strengths.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29328521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Areas covered: An overview of 7T MRI applications in MS focusing on increased sensitivity for lesion detection, specificity of the central vein sign and better understanding of MS pathophysiology. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29369733",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29514948",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "OBJECTIVE: To assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29514948",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that the CVS on 3T MRI accurately distinguishes patients with MS from those with seropositive NMOSD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29514948",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31424490",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Objective\n\nTo evaluate the sensitivity and specificity of various central vein sign lesion criteria for differentiating MS from non-MS conditions using 3T brain MRI with various commonly used pulse sequences.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31424490",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The sensitivity was 68.1% and specificity was 82.9% for distinguishing MS from not MS using a 35% central vein sign proportion threshold.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31424490",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Importance\n\nThe central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (MRI) studies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31424490",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Conclusions and Relevance\n\nIn this study, use of the central vein sign at 3T MRI yielded a high specificity and a moderate sensitivity in differentiating MS from not MS; international, multicenter studies may be needed to ascertain whether the central vein sign-based criteria can accurately detect MS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31424490",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Conclusion The presence of the central vein sign on susceptibility-weighted images for MS lesions improves the understanding of the periventricular distribution of MS lesions and could contribute as adjunctive diagnostic criteria for MS disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29565219",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The central vein sign should be considered as a diagnostic biomarker in MS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31668125",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The central vein sign has the potential to be a non-invasive, MS-specific biomarker.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31668125",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Original articles investigating central vein sign on T2*-weighted images of patients with MS were selected.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31796822",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND AND PURPOSE\n\nThe central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30213803",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The central vein sign should be considered as a diagnostic biomarker in MS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31668125",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30213803",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The central vein sign ( CVS ) has recently been proposed as a novel MRI biomarker to improve the accuracy and speed of MS diagnosis . ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27834394",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recent studies have demonstrated that patients with MS have higher proportions of white matter lesions with the central vein sign compared with those with diseases that mimic MS on MR imaging . ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30213803",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Conclusion The presence of the central vein sign on susceptibility-weighted images for MS lesions improves the understanding of the periventricular distribution of MS lesions and could contribute as adjunctive diagnostic criteria for MS disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29565219",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTERPRETATION\nThe central vein sign differentiates inflammatory CNS vasculopathies from MS at standard clinical magnetic field strengths.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29328521",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The central vein sign has the potential to be a non-invasive, MS-specific biomarker.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31668125",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The central vein sign should be considered as a diagnostic biomarker in MS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31668125",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE\nPrevious T2*-weighted magnetic resonance imaging (MRI) studies have used white matter lesion (WML) central veins to distinguish multiple sclerosis (MS) from its mimics.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27300318",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Recent studies have demonstrated that patients with MS have higher proportions of white matter lesions with the central vein sign compared with those with diseases that mimic MS on MR imaging.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30213803",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "When a threshold of 50% perivenular lesions was applied, central vein sign discriminated MS from inflammatory vasculopathies with a diagnostic accuracy of 100%.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29328521",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "multiple sclerosis"
}